Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2013800681
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2013800681
Title / Product Name
KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2013800681
EP Publication Number
2858985
E-Number
990312
Language
EN
PCT Number
US13044116
Publication Date
15.04.2015 A
18.04.2018 B1
Registration Date
18.04.2018
AT Publication Date
15.05.2018
Application Date
04.06.2013
Registration Number
-
Priorities
07.06.2012
US
201261656888 P
IPC
C07D 401/04 20060101AFI20160413BHEP
Maximum Duration of Protection
04.06.2033
Owner
Aragon Pharmaceuticals, Inc.
12780 El Camino Real, Suite 301
San Diego, CA 92130
US
Sloan-Kettering Institute for Cancer Research
1275 York Avenue
New York, NY 10065
US
Representative
Representative
Häupl & Ellmeyer KG Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
SMITH, Nicholas, D.
1204 Beryl Street
San Diego, CA 92109
US
HERBERT, Mark, R.
4180 Amoroso St.
San Diego, CA 92111
US
OUERFELLI, Ouathek
2077 Center Avenue Apt. 3J
Fort Lee, NJ 07024
US
DILHAS, Anna
Häsingerstrasse 32
4055 Basel
CH
Information about Fees
Click here to load the fees
see.ip - Details for KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS